Listed

AN2 Therapeutics, Inc.: Form 8-K, filed Nov 5, 2024

Filed with the SEC on Nov 5, 2024 and accepted by EDGAR at Nov 5, 2024, 16:05 ET.

Share

Items reported

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Source: SEC EDGAR, the filing index for accession 0001193125-24-251240. Last ingested by Listed: Nov 15, 2026, 04:15 ET. Listed shows no prices and gives no investment advice.